New WHO Director Calls On Board To Join In “Intensive” Period Of Change 22/01/2018 Catherine Saez All human beings should receive the health services they need without suffering financial hardship, such is the definition of universal health coverage, a key point of discussion at the World Health Organization Executive Board meeting this week. New WHO Director General Tedros Adhanom Ghebreyesus (Dr Tedros) opened the event by presenting his vision for the future, and the collective work to accomplish necessary changes to the UN health agency. The European Union and United States warned against politicisation of the WHO. Continue reading -> WHO’s Revised Work Programme: Evidence-Based Normative Work, Access To Medicines 08/01/2018 Catherine Saez In a couple of weeks, the World Health Organization will be holding its annual January Executive Board meeting. Delegates will consider the edited version of the draft 13th WHO general programme of work for 2019-2023, published on 5 January. Following comments to the first version of the programme in November, the secretariat produced a more fleshed-out document, emphasizing the WHO's normative role, in particular evidence-based. The necessity of access to medicines and vaccines has been extended to other products, such as devices and blood products, and mention is made of the WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Continue reading -> TWN – Proposed WHO Criteria On Medicines In Transit Open Door For Seizures 28/11/2017 Guest contributor Geneva, 21 Nov (TWN) - A discussion document prepared by the Secretariat of the World Health Organization (WHO) proposes criteria to justify interventions with respect to medicines in transit. This document is prepared for the 6th meeting of the Member State Mechanism (MSM) to be held from 28 November to 1 December at the WHO headquarters in Geneva, writes Third World Network. Continue reading -> First Consultations Held On WHO Pandemic Flu Framework Options 10/11/2017 Catherine Saez The World Health Organization is consulting member states and stakeholders on the future of its mechanism to help prepare the world for the next influenza pandemic. It is particularly asking whether countries should submit not only the biological samples of their influenza viruses, but also their genetic information through the mechanism. Also in question is whether the mechanism should be extended to cover seasonal influenza. Stakeholders had different views but all questioned the absence of recognition by the WHO of a widely used database currently hosting most of the world’s influenza genetic information. Continue reading -> WHO Issues Guidelines Against Antibiotic Overuse In Farms And Food Industry 07/11/2017 Catherine Saez Against the growing threat of a world where bacteria can kill again because they have developed resistance to available antibiotics, and the lack of new promising options in the research pipeline, several international agencies are seeking solutions. The World Health Organization today published a set of recommendations to help stop the routine use of antibiotics to promote growth and prevent disease in healthy animals. Continue reading -> WHO Draft 5-Year Plan Would Focus On Impact & Innovation, Be Discreet On Medicines Access 25/10/2017 Catherine Saez After the new head of the World Health Organization provided his vision for his tenure of the global health institution this summer, the organisation is working on its next programme of work for the period 2019-2023. A preliminary concept note has been issued for public consideration. The note lays out priorities and new orientations and describes a financially sober, more efficient organisation, focused on measurable impact, set on aligning with the United Nations Sustainable Development Goals, and affirming its role as a multi-stakeholder platform of global governance on health, but stays clear of controversial issues, such as the affordability of medicines. Continue reading -> Consultation On Future Of WHO Pandemic Flu Programme To Look At Seasonal Viruses, Genetic Information 24/10/2017 Catherine Saez The World Health Organization mechanism to prepare the world for the next influenza pandemic is pondering its future and possible improvements. Among them are its extension to seasonal influenza, and the inclusion of genetic virus information along with biological samples to keep pace with technological developments. Member states and stakeholders (except the media) have been invited by the WHO to a consultation next month to discuss an analysis showing the potential beneficial or deleterious effects of the suggested changes to the system. Continue reading -> WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Better Data On Fake Drugs Needed To Fight The Scourge 30/08/2017 Tatum Anderson The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO. Continue reading -> WHO Director-Elect Tedros In US, Meeting With Funders, International Organisations, Governments 12/06/2017 William New World Health Organization Director-Elect Tedros Adhanom Ghebreyesus in touring the United States this week, visiting key funders of the WHO, partner international organisations, US government agencies and nongovernmental organisations, and a Canadian ministry. Continue reading -> Posts navigation Older postsNewer posts
WHO’s Revised Work Programme: Evidence-Based Normative Work, Access To Medicines 08/01/2018 Catherine Saez In a couple of weeks, the World Health Organization will be holding its annual January Executive Board meeting. Delegates will consider the edited version of the draft 13th WHO general programme of work for 2019-2023, published on 5 January. Following comments to the first version of the programme in November, the secretariat produced a more fleshed-out document, emphasizing the WHO's normative role, in particular evidence-based. The necessity of access to medicines and vaccines has been extended to other products, such as devices and blood products, and mention is made of the WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Continue reading -> TWN – Proposed WHO Criteria On Medicines In Transit Open Door For Seizures 28/11/2017 Guest contributor Geneva, 21 Nov (TWN) - A discussion document prepared by the Secretariat of the World Health Organization (WHO) proposes criteria to justify interventions with respect to medicines in transit. This document is prepared for the 6th meeting of the Member State Mechanism (MSM) to be held from 28 November to 1 December at the WHO headquarters in Geneva, writes Third World Network. Continue reading -> First Consultations Held On WHO Pandemic Flu Framework Options 10/11/2017 Catherine Saez The World Health Organization is consulting member states and stakeholders on the future of its mechanism to help prepare the world for the next influenza pandemic. It is particularly asking whether countries should submit not only the biological samples of their influenza viruses, but also their genetic information through the mechanism. Also in question is whether the mechanism should be extended to cover seasonal influenza. Stakeholders had different views but all questioned the absence of recognition by the WHO of a widely used database currently hosting most of the world’s influenza genetic information. Continue reading -> WHO Issues Guidelines Against Antibiotic Overuse In Farms And Food Industry 07/11/2017 Catherine Saez Against the growing threat of a world where bacteria can kill again because they have developed resistance to available antibiotics, and the lack of new promising options in the research pipeline, several international agencies are seeking solutions. The World Health Organization today published a set of recommendations to help stop the routine use of antibiotics to promote growth and prevent disease in healthy animals. Continue reading -> WHO Draft 5-Year Plan Would Focus On Impact & Innovation, Be Discreet On Medicines Access 25/10/2017 Catherine Saez After the new head of the World Health Organization provided his vision for his tenure of the global health institution this summer, the organisation is working on its next programme of work for the period 2019-2023. A preliminary concept note has been issued for public consideration. The note lays out priorities and new orientations and describes a financially sober, more efficient organisation, focused on measurable impact, set on aligning with the United Nations Sustainable Development Goals, and affirming its role as a multi-stakeholder platform of global governance on health, but stays clear of controversial issues, such as the affordability of medicines. Continue reading -> Consultation On Future Of WHO Pandemic Flu Programme To Look At Seasonal Viruses, Genetic Information 24/10/2017 Catherine Saez The World Health Organization mechanism to prepare the world for the next influenza pandemic is pondering its future and possible improvements. Among them are its extension to seasonal influenza, and the inclusion of genetic virus information along with biological samples to keep pace with technological developments. Member states and stakeholders (except the media) have been invited by the WHO to a consultation next month to discuss an analysis showing the potential beneficial or deleterious effects of the suggested changes to the system. Continue reading -> WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Better Data On Fake Drugs Needed To Fight The Scourge 30/08/2017 Tatum Anderson The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO. Continue reading -> WHO Director-Elect Tedros In US, Meeting With Funders, International Organisations, Governments 12/06/2017 William New World Health Organization Director-Elect Tedros Adhanom Ghebreyesus in touring the United States this week, visiting key funders of the WHO, partner international organisations, US government agencies and nongovernmental organisations, and a Canadian ministry. Continue reading -> Posts navigation Older postsNewer posts
TWN – Proposed WHO Criteria On Medicines In Transit Open Door For Seizures 28/11/2017 Guest contributor Geneva, 21 Nov (TWN) - A discussion document prepared by the Secretariat of the World Health Organization (WHO) proposes criteria to justify interventions with respect to medicines in transit. This document is prepared for the 6th meeting of the Member State Mechanism (MSM) to be held from 28 November to 1 December at the WHO headquarters in Geneva, writes Third World Network. Continue reading -> First Consultations Held On WHO Pandemic Flu Framework Options 10/11/2017 Catherine Saez The World Health Organization is consulting member states and stakeholders on the future of its mechanism to help prepare the world for the next influenza pandemic. It is particularly asking whether countries should submit not only the biological samples of their influenza viruses, but also their genetic information through the mechanism. Also in question is whether the mechanism should be extended to cover seasonal influenza. Stakeholders had different views but all questioned the absence of recognition by the WHO of a widely used database currently hosting most of the world’s influenza genetic information. Continue reading -> WHO Issues Guidelines Against Antibiotic Overuse In Farms And Food Industry 07/11/2017 Catherine Saez Against the growing threat of a world where bacteria can kill again because they have developed resistance to available antibiotics, and the lack of new promising options in the research pipeline, several international agencies are seeking solutions. The World Health Organization today published a set of recommendations to help stop the routine use of antibiotics to promote growth and prevent disease in healthy animals. Continue reading -> WHO Draft 5-Year Plan Would Focus On Impact & Innovation, Be Discreet On Medicines Access 25/10/2017 Catherine Saez After the new head of the World Health Organization provided his vision for his tenure of the global health institution this summer, the organisation is working on its next programme of work for the period 2019-2023. A preliminary concept note has been issued for public consideration. The note lays out priorities and new orientations and describes a financially sober, more efficient organisation, focused on measurable impact, set on aligning with the United Nations Sustainable Development Goals, and affirming its role as a multi-stakeholder platform of global governance on health, but stays clear of controversial issues, such as the affordability of medicines. Continue reading -> Consultation On Future Of WHO Pandemic Flu Programme To Look At Seasonal Viruses, Genetic Information 24/10/2017 Catherine Saez The World Health Organization mechanism to prepare the world for the next influenza pandemic is pondering its future and possible improvements. Among them are its extension to seasonal influenza, and the inclusion of genetic virus information along with biological samples to keep pace with technological developments. Member states and stakeholders (except the media) have been invited by the WHO to a consultation next month to discuss an analysis showing the potential beneficial or deleterious effects of the suggested changes to the system. Continue reading -> WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Better Data On Fake Drugs Needed To Fight The Scourge 30/08/2017 Tatum Anderson The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO. Continue reading -> WHO Director-Elect Tedros In US, Meeting With Funders, International Organisations, Governments 12/06/2017 William New World Health Organization Director-Elect Tedros Adhanom Ghebreyesus in touring the United States this week, visiting key funders of the WHO, partner international organisations, US government agencies and nongovernmental organisations, and a Canadian ministry. Continue reading -> Posts navigation Older postsNewer posts
First Consultations Held On WHO Pandemic Flu Framework Options 10/11/2017 Catherine Saez The World Health Organization is consulting member states and stakeholders on the future of its mechanism to help prepare the world for the next influenza pandemic. It is particularly asking whether countries should submit not only the biological samples of their influenza viruses, but also their genetic information through the mechanism. Also in question is whether the mechanism should be extended to cover seasonal influenza. Stakeholders had different views but all questioned the absence of recognition by the WHO of a widely used database currently hosting most of the world’s influenza genetic information. Continue reading -> WHO Issues Guidelines Against Antibiotic Overuse In Farms And Food Industry 07/11/2017 Catherine Saez Against the growing threat of a world where bacteria can kill again because they have developed resistance to available antibiotics, and the lack of new promising options in the research pipeline, several international agencies are seeking solutions. The World Health Organization today published a set of recommendations to help stop the routine use of antibiotics to promote growth and prevent disease in healthy animals. Continue reading -> WHO Draft 5-Year Plan Would Focus On Impact & Innovation, Be Discreet On Medicines Access 25/10/2017 Catherine Saez After the new head of the World Health Organization provided his vision for his tenure of the global health institution this summer, the organisation is working on its next programme of work for the period 2019-2023. A preliminary concept note has been issued for public consideration. The note lays out priorities and new orientations and describes a financially sober, more efficient organisation, focused on measurable impact, set on aligning with the United Nations Sustainable Development Goals, and affirming its role as a multi-stakeholder platform of global governance on health, but stays clear of controversial issues, such as the affordability of medicines. Continue reading -> Consultation On Future Of WHO Pandemic Flu Programme To Look At Seasonal Viruses, Genetic Information 24/10/2017 Catherine Saez The World Health Organization mechanism to prepare the world for the next influenza pandemic is pondering its future and possible improvements. Among them are its extension to seasonal influenza, and the inclusion of genetic virus information along with biological samples to keep pace with technological developments. Member states and stakeholders (except the media) have been invited by the WHO to a consultation next month to discuss an analysis showing the potential beneficial or deleterious effects of the suggested changes to the system. Continue reading -> WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Better Data On Fake Drugs Needed To Fight The Scourge 30/08/2017 Tatum Anderson The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO. Continue reading -> WHO Director-Elect Tedros In US, Meeting With Funders, International Organisations, Governments 12/06/2017 William New World Health Organization Director-Elect Tedros Adhanom Ghebreyesus in touring the United States this week, visiting key funders of the WHO, partner international organisations, US government agencies and nongovernmental organisations, and a Canadian ministry. Continue reading -> Posts navigation Older postsNewer posts
WHO Issues Guidelines Against Antibiotic Overuse In Farms And Food Industry 07/11/2017 Catherine Saez Against the growing threat of a world where bacteria can kill again because they have developed resistance to available antibiotics, and the lack of new promising options in the research pipeline, several international agencies are seeking solutions. The World Health Organization today published a set of recommendations to help stop the routine use of antibiotics to promote growth and prevent disease in healthy animals. Continue reading -> WHO Draft 5-Year Plan Would Focus On Impact & Innovation, Be Discreet On Medicines Access 25/10/2017 Catherine Saez After the new head of the World Health Organization provided his vision for his tenure of the global health institution this summer, the organisation is working on its next programme of work for the period 2019-2023. A preliminary concept note has been issued for public consideration. The note lays out priorities and new orientations and describes a financially sober, more efficient organisation, focused on measurable impact, set on aligning with the United Nations Sustainable Development Goals, and affirming its role as a multi-stakeholder platform of global governance on health, but stays clear of controversial issues, such as the affordability of medicines. Continue reading -> Consultation On Future Of WHO Pandemic Flu Programme To Look At Seasonal Viruses, Genetic Information 24/10/2017 Catherine Saez The World Health Organization mechanism to prepare the world for the next influenza pandemic is pondering its future and possible improvements. Among them are its extension to seasonal influenza, and the inclusion of genetic virus information along with biological samples to keep pace with technological developments. Member states and stakeholders (except the media) have been invited by the WHO to a consultation next month to discuss an analysis showing the potential beneficial or deleterious effects of the suggested changes to the system. Continue reading -> WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Better Data On Fake Drugs Needed To Fight The Scourge 30/08/2017 Tatum Anderson The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO. Continue reading -> WHO Director-Elect Tedros In US, Meeting With Funders, International Organisations, Governments 12/06/2017 William New World Health Organization Director-Elect Tedros Adhanom Ghebreyesus in touring the United States this week, visiting key funders of the WHO, partner international organisations, US government agencies and nongovernmental organisations, and a Canadian ministry. Continue reading -> Posts navigation Older postsNewer posts
WHO Draft 5-Year Plan Would Focus On Impact & Innovation, Be Discreet On Medicines Access 25/10/2017 Catherine Saez After the new head of the World Health Organization provided his vision for his tenure of the global health institution this summer, the organisation is working on its next programme of work for the period 2019-2023. A preliminary concept note has been issued for public consideration. The note lays out priorities and new orientations and describes a financially sober, more efficient organisation, focused on measurable impact, set on aligning with the United Nations Sustainable Development Goals, and affirming its role as a multi-stakeholder platform of global governance on health, but stays clear of controversial issues, such as the affordability of medicines. Continue reading -> Consultation On Future Of WHO Pandemic Flu Programme To Look At Seasonal Viruses, Genetic Information 24/10/2017 Catherine Saez The World Health Organization mechanism to prepare the world for the next influenza pandemic is pondering its future and possible improvements. Among them are its extension to seasonal influenza, and the inclusion of genetic virus information along with biological samples to keep pace with technological developments. Member states and stakeholders (except the media) have been invited by the WHO to a consultation next month to discuss an analysis showing the potential beneficial or deleterious effects of the suggested changes to the system. Continue reading -> WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Better Data On Fake Drugs Needed To Fight The Scourge 30/08/2017 Tatum Anderson The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO. Continue reading -> WHO Director-Elect Tedros In US, Meeting With Funders, International Organisations, Governments 12/06/2017 William New World Health Organization Director-Elect Tedros Adhanom Ghebreyesus in touring the United States this week, visiting key funders of the WHO, partner international organisations, US government agencies and nongovernmental organisations, and a Canadian ministry. Continue reading -> Posts navigation Older postsNewer posts
Consultation On Future Of WHO Pandemic Flu Programme To Look At Seasonal Viruses, Genetic Information 24/10/2017 Catherine Saez The World Health Organization mechanism to prepare the world for the next influenza pandemic is pondering its future and possible improvements. Among them are its extension to seasonal influenza, and the inclusion of genetic virus information along with biological samples to keep pace with technological developments. Member states and stakeholders (except the media) have been invited by the WHO to a consultation next month to discuss an analysis showing the potential beneficial or deleterious effects of the suggested changes to the system. Continue reading -> WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Better Data On Fake Drugs Needed To Fight The Scourge 30/08/2017 Tatum Anderson The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO. Continue reading -> WHO Director-Elect Tedros In US, Meeting With Funders, International Organisations, Governments 12/06/2017 William New World Health Organization Director-Elect Tedros Adhanom Ghebreyesus in touring the United States this week, visiting key funders of the WHO, partner international organisations, US government agencies and nongovernmental organisations, and a Canadian ministry. Continue reading -> Posts navigation Older postsNewer posts
WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Better Data On Fake Drugs Needed To Fight The Scourge 30/08/2017 Tatum Anderson The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO. Continue reading -> WHO Director-Elect Tedros In US, Meeting With Funders, International Organisations, Governments 12/06/2017 William New World Health Organization Director-Elect Tedros Adhanom Ghebreyesus in touring the United States this week, visiting key funders of the WHO, partner international organisations, US government agencies and nongovernmental organisations, and a Canadian ministry. Continue reading -> Posts navigation Older postsNewer posts
Better Data On Fake Drugs Needed To Fight The Scourge 30/08/2017 Tatum Anderson The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO. Continue reading -> WHO Director-Elect Tedros In US, Meeting With Funders, International Organisations, Governments 12/06/2017 William New World Health Organization Director-Elect Tedros Adhanom Ghebreyesus in touring the United States this week, visiting key funders of the WHO, partner international organisations, US government agencies and nongovernmental organisations, and a Canadian ministry. Continue reading -> Posts navigation Older postsNewer posts
WHO Director-Elect Tedros In US, Meeting With Funders, International Organisations, Governments 12/06/2017 William New World Health Organization Director-Elect Tedros Adhanom Ghebreyesus in touring the United States this week, visiting key funders of the WHO, partner international organisations, US government agencies and nongovernmental organisations, and a Canadian ministry. Continue reading -> Posts navigation Older postsNewer posts